List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 33 studies with search of: Leishmaniasis | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: Sodium Stibogluconate (SSG)
2 Recruiting Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396
Condition: Cutaneous Leishmaniasis
Intervention: Drug: WR 279,396
3 Not yet recruiting Miltefosine to Treat Mucocutaneous Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Cutaneous Leishmaniasis
Intervention: Drug: miltefosine
4 Recruiting To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
Condition: Leishmaniasis, Visceral
Interventions: Drug: Amphotericin B Lipid emulsion;   Drug: Liposomal Amphotericin B
5 Available Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Conditions: Leishmaniasis, Cutaneous;   Leishmaniasis, Mucocutaneous
Intervention: Drug: sodium stibogluconate (Pentostam)
6 Recruiting Surveillance for Leishmaniasis Skin Lesions in Mali
Condition: Cutaneous Leishmaniasis
Intervention:
7 Not yet recruiting Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Procedure: Photodynamic therapy;   Procedure: Cryotherapy
8 Recruiting Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: N-metil glucamine;   Drug: Azithromycin
9 Recruiting A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Biological: LEISH-F2 + MPL-SE;   Drug: Sodium stibogluconate
10 Recruiting Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Paromomycin sulfate
11 Recruiting Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
Condition: Leishmaniasis, Cutaneous
Interventions: Drug: meglumine antimoniate, allopurinol;   Drug: meglumine antimoniate
12 Recruiting Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients
Condition: Localized Cutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
13 Recruiting Short Course of Miltefosine and Liposomal Amphotericin B for Kala-Azar
Condition: Visceral Leishmaniasis
Intervention: Drug: Liposomal amphotericin B and Miltefosine
14 Recruiting Safety, Tolerability, and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine in Combination With Sodium Stibogluconate (SSG) in the Treatment of Patients With Post Kala-Azar Dermal Leishmaniasis (PKDL)
Condition: Post Kala Azar Dermal Leishmaniasis
Intervention: Biological: LEISH-F2 + MPL-SE vaccine
15 Recruiting Expression of Mif Alleles in Individuals With Leishmaniasis
Condition: Leishmaniasis
Intervention:
16 Recruiting Immunogenetics of Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention:
17 Not yet recruiting Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)
Condition: Leishmaniasis, Cutaneous
Interventions: Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream);   Drug: Paromomycin Alone Cream (15% paromomycin topical cream)
18 Recruiting Controlled Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396 topical cream;   Drug: Paromomycin topical cream;   Drug: Topical cream placebo
19 Recruiting Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Amphotericin B Deoxycholate;   Drug: Ambisome + Miltefosine;   Drug: Ambisome and Paromomycin;   Drug: Miltefosine and Paromomycin
20 Recruiting Combination Therapy in Indian Visceral Leishmaniasis
Condition: Leishmaniasis, Visceral
Interventions: Drug: amphotericin B deoxycholate;   Drug: Liposomal Amphotericin B with Miltefosine;   Drug: Liposomal Amphotericin B and Paromomycin Sulfate;   Drug: miltefosine + Paromomycin sulfate

Previous Page Studies Shown (1-20) Next Page (21-33)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services